Notable Labs Operating Margin 2013-2024 | NTBLQ

Current and historical operating margin for Notable Labs (NTBLQ) over the last 10 years. The current operating profit margin for Notable Labs as of June 30, 2024 is 0.00%.
Notable Labs Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-12-31 $-0.00B $-0.01B 1300.00%
2022-09-30 $0.00B $-0.04B inf%
2022-06-30 $0.00B $-0.04B inf%
2022-03-31 $0.00B $-0.04B inf%
2021-12-31 $0.00B $-0.03B inf%
2021-09-30 $0.00B $-0.03B inf%
2021-06-30 $0.00B $-0.03B inf%
2021-03-31 $0.00B $-0.03B inf%
2020-12-31 $0.00B $-0.03B inf%
2020-09-30 $0.00B $-0.02B inf%
2020-06-30 $0.00B $-0.02B inf%
2020-03-31 $0.00B $-0.02B inf%
2019-12-31 $0.00B $-0.02B inf%
2019-09-30 $0.00B $-0.02B inf%
2019-06-30 $0.00B $-0.02B inf%
2019-03-31 $0.00B $-0.02B inf%
2018-12-31 $0.00B $-0.02B inf%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00